Itron (NASDAQ:ITRI) Rating Reiterated by Roth Mkm

Itron (NASDAQ:ITRI)‘s stock had its “buy” rating reissued by research analysts at Roth Mkm in a research note issued on Tuesday, Benzinga reports. They currently have a $102.00 price target on the scientific and technical instruments company’s stock. Roth Mkm’s target price indicates a potential upside of 8.03% from the company’s previous close.

ITRI has been the subject of a number of other research reports. Raymond James downgraded shares of Itron from an “outperform” rating to a “market perform” rating in a report on Thursday, January 4th. Canaccord Genuity Group upgraded shares of Itron from a “hold” rating to a “buy” rating and increased their price objective for the company from $68.00 to $105.00 in a research note on Tuesday, February 27th. Piper Sandler dropped their price objective on shares of Itron from $105.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, April 11th. Canaccord Genuity Group upgraded shares of Itron from a “hold” rating to a “buy” rating and raised their target price for the company from $68.00 to $105.00 in a research note on Tuesday, February 27th. Finally, Oppenheimer upgraded shares of Itron from a “market perform” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Friday, January 19th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $97.60.

Itron Price Performance

Shares of NASDAQ ITRI opened at $94.42 on Tuesday. Itron has a twelve month low of $50.60 and a twelve month high of $96.73. The firm has a market cap of $4.33 billion, a P/E ratio of 44.96, a PEG ratio of 1.01 and a beta of 1.41. The company has a 50 day moving average of $88.66 and a 200 day moving average of $75.52. The company has a quick ratio of 1.43, a current ratio of 1.95 and a debt-to-equity ratio of 0.34.

Itron (NASDAQ:ITRI) last announced its earnings results on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.48. The business had revenue of $577.17 million during the quarter, compared to analyst estimates of $569.90 million. Itron had a net margin of 4.46% and a return on equity of 12.27%. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.71 EPS. As a group, research analysts expect that Itron will post 3.61 EPS for the current fiscal year.

Insider Transactions at Itron

In other Itron news, Director Jerome J. Lande sold 14,896 shares of Itron stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $95.25, for a total value of $1,418,844.00. Following the completion of the sale, the director now owns 5,750 shares in the company, valued at approximately $547,687.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Itron news, SVP Donald L. Reeves III sold 383 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total value of $28,866.71. Following the transaction, the senior vice president now directly owns 8,708 shares of the company’s stock, valued at approximately $656,321.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jerome J. Lande sold 14,896 shares of the business’s stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $95.25, for a total value of $1,418,844.00. Following the completion of the sale, the director now owns 5,750 shares of the company’s stock, valued at $547,687.50. The disclosure for this sale can be found here. Insiders sold 30,467 shares of company stock valued at $2,752,520 in the last 90 days. 1.45% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Itron

A number of institutional investors have recently made changes to their positions in the company. Contravisory Investment Management Inc. grew its stake in shares of Itron by 61.5% in the first quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 131 shares in the last quarter. GAMMA Investing LLC purchased a new stake in shares of Itron during the fourth quarter valued at $27,000. Covestor Ltd lifted its holdings in shares of Itron by 9,150.0% during the third quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 549 shares during the last quarter. Harvest Fund Management Co. Ltd purchased a new stake in shares of Itron during the fourth quarter valued at $50,000. Finally, C M Bidwell & Associates Ltd. purchased a new stake in Itron in the 4th quarter worth about $76,000. 96.19% of the stock is currently owned by institutional investors.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.